Thoracic Imaging

Solitary Pulmonary Nodules: Potential Role of Dynamic MR Imaging in Management—Initial Experience

Published Online:Aug 1 2002https://doi.org/10.1148/radiol.2242010992

Abstract

PURPOSE: To evaluate the utility of dynamic magnetic resonance (MR) imaging in the management of solitary pulmonary nodules (SPNs).

MATERIALS AND METHODS: Fifty-eight patients with 58 pathologic analysis–proved SPNs (diameter < 30 mm) underwent dynamic 1.5-T MR imaging. The 58 SPNs were classified into three groups at pathologic analysis: malignant SPNs (n = 38), active infections (n = 10), or benign SPNs (n = 10). From signal intensity–time curves generated after the bolus injection of contrast material, the maximum relative enhancement ratio and slope of enhancement were calculated and statistically compared among the three groups. Threshold values of these two dynamic MR indexes were determined on the basis of positive differentiations.

RESULTS: The mean relative enhancement ratio and mean slope of enhancement for the malignant SPN group were significantly higher than those for the benign SPN group and significantly lower than those for the active infection group (P < .05). With 0.15 as the threshold maximum relative enhancement ratio for distinguishing the malignant SPN and active infection groups from the benign SPN group, the sensitivity, specificity, and accuracy were 100%, 70%, and 95%, respectively. With 0.025/sec as the threshold slope of enhancement, all SPNs with malignancy and active infection were clearly distinguished from benign SPNs.

CONCLUSION: Dynamic MR indexes were useful in the differentiation between SPNs that necessitated further evaluation or treatment (malignancy and active infection) and SPNs that did not necessitate further evaluation or treatment (benign nodules).

References

1 Swensen SJ, Morin RL, Schueler BA, et al. Solitary pulmonary nodule: CT evaluation of enhancement with iodinated contrast media—a preliminary report. Radiology 1992; 182:343-347.
Google Scholar
2 Swensen SJ, Brown LR, Colby TV, Weaver AL, Midthum DE. Lung nodule enhancement at CT: prospective findings. Radiology 1996; 201:447-455.
Google Scholar
3 Yamashita K, Matsnobe S, Tsuda T, et al. Solitary pulmonary nodules: preliminary study of evaluation with incremental dynamic CT. Radiology 1995; 194:399-405.
Google Scholar
4 Zhang M, Kono M. Solitary pulmonary nodules: evaluation of blood flow patterns with dynamic CT. Radiology 1997; 205:471-478.
Google Scholar
5 Swensen SJ, Viggiano RW, Midthun DE, et al. Lung nodule enhancement at CT: multicenter study. Radiology 2000; 214:73-80.
Google Scholar
6 Patz EF, Jr, Lowe VJ, Hoffman JM, et al. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 1993; 188:487-490.
Google Scholar
7 Dewan NA, Gupta NC, Redepenning LS, Phalen JJ, Frick MP. Diagnostic efficiency of PET-FDG imaging in solitary pulmonary nodules. Chest 1993; 104:997-1002.
MedlineGoogle Scholar
8 Webb WR. Radiologic evaluation of the solitary pulmonary nodule. AJR Am J Roentgenol 1990; 154:701-708.
MedlineGoogle Scholar
9 Gaera M, Barone M, Russi EG, et al. Carcinomatous solitary pulmonary nodules: evaluation of the tumor-bronchi relationship with thin-section CT. Radiology 1993; 187:535-539.
Google Scholar
10 Kusumoto M, Kono M, Adachi S, et al. Gadopentetate dimeglumine-enhanced magnetic resonance imaging for lung nodules: differentiation of lung cancer and tuberculoma. Invest Radiol 1994; 29:S255-S256.
MedlineGoogle Scholar
11 Guckel C, Schnabel K, Deimling M, Steinbrich W. Solitary pulmonary nodules: MR evaluation of enhancement patterns with contrast-enhanced dynamic snapshot gradient-echo imaging. Radiology 1996; 200:681-686.
Google Scholar
12 Kono M, Adachi S, Kusumoto M, Sakai E. Clinical utility of Gd-DTPA–enhanced magnetic resonance imaging in lung cancer. J Thorac Imaging 1993; 8:18-26.
MedlineGoogle Scholar
13 Milne ENC. Circulation of primary and metastatic pulmonary neoplasm: a postmortem microarteriographic study. Am J Roentgenol Radium Ther Nucl Med 1967; 100:603-619.
MedlineGoogle Scholar
14 Milne ENC, Zerhouni EA. Blood supply of pulmonary metastases. J Thorac Imaging 1987; 2:15-23.
MedlineGoogle Scholar
15 Flier JS, Mueckler MM, Usher P, Lodish HF. Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science 1987; 235:1492-1495.
MedlineGoogle Scholar
16 Gallagher BM, Fowler JS, Gutterson NI, et al. Metabolic trapping as a principle of radiopharmaceutical design: some factors responsible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose. J Nucl Med 1978; 19:1154-1161.
MedlineGoogle Scholar
17 Gupta NC, Aloof J, Gunnel E. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. J Nucl Med 1996; 37:943-948.
MedlineGoogle Scholar
18 Worsley DF, Seller A, Adam MJ, et al. Pulmonary nodules: differential diagnosis using 18F-fluorodeoxyglucose single-photon emission computed tomography. AJR Am J Roentgenol 1997; 168:771-774.
MedlineGoogle Scholar
19 Prater HW, Weber WA, Romer W, Truman T, Ziegler SI, Schweigger M. Controlled prospective study of positron emission tomography using the glucose analogue [18F]fluorodeoxyglucose in the evaluation of pulmonary nodules. Br J Surg 1998; 85:1506-1511.
MedlineGoogle Scholar
20 Stumps KD, Dazzi H, Schaffner A, von Schulthess GK. Infection imaging using whole-body FDG-PET. Eur J Nucl Med 2000; 27:822-832.
MedlineGoogle Scholar
21 Goo JM, Im JG, Do KH, et al. Pulmonary tuberculoma evaluated by means of FDG PET: findings in 10 cases. Radiology 2000; 216:117-121.
Google Scholar
22 Goldsmith SJ, Kostakoglu L. Role of nuclear medicine in the evaluation of the solitary pulmonary nodule. Semin Ultrasound CT MR 2000; 21:129-138.
MedlineGoogle Scholar
23 Ichikawa T, Araki T. Fast magnetic resonance imaging of liver. Eur J Radiol 1999; 29:186-210.
MedlineGoogle Scholar
24 Baba Y, Yamashita Y, Onomichi M, et al. Dynamic magnetic resonance imaging of head and neck lesions. Top Magn Reson Imaging 1999; 10:125-129.
MedlineGoogle Scholar
25 Ercolani P, Valeri G, Amici F. Dynamic MRI of the breast. Eur J Radiol 1998; 27:S265-S271.
MedlineGoogle Scholar
26 Hatabu H, Gaa J, Kim D, et al. Pulmonary perfusion and angiography: evaluation with breath-hold enhanced three-dimensional fast imaging steady-state precession MR imaging with short TR and TE. AJR Am J Roentgenol 1996; 167:653-655.
MedlineGoogle Scholar
27 Hatabu H, Gaa J, Kim D, et al. Pulmonary perfusion: quantitative assessment with dynamic contrast-enhanced MRI using ultra-short TE and inversion recovery turbo FLASH. Magn Reson Med 1996; 36:503-508.
MedlineGoogle Scholar
28 Hatabu H, Alsop DC, Listerud J, Bonnet M, Gefter WB. T2* and proton density measurement of normal human lung parenchyma using submillisecond echo time gradient echo magnetic resonance imaging. Eur J Radiol 1999; 29:245-252.
MedlineGoogle Scholar
29 Hatabu H, Chen Q, Stock KW, Gefter WB, Itoh H. Fast magnetic resonance imaging of the lung. Eur J Radiol 1999; 29:114-13.
MedlineGoogle Scholar
30 Hatabu H, Tadamura E, Levin DL, et al. Quantitative assessment of pulmonary perfusion with dynamic contrast-enhanced MRI. Magn Reson Med 1999; 42:1033-1038.
MedlineGoogle Scholar
31 Littleton JT, Durizch ML, Moeller G, Herbert DE. Pulmonary masses: contrast enhancement. Radiology 1990; 177:861-871.
Google Scholar
32 Dean PB, Niemi P, Kivisaari L, Kormano M. Comparative pharmacokinetics of gadolinium DTPA and gadolinium chloride. Invest Radiol 1988; 23:S258-S260.
MedlineGoogle Scholar
33 Frouge C, Guinebretiere JM, Contesso G, et al. Correlation between contrast enhancement in dynamic magnetic resonance imaging of the breast and tumor angiogenesis. Invest Radiol 1994; 29:1043-1049.
MedlineGoogle Scholar
34 Sipkins DA, Cheresh DA, Kazemi MR, et al. Detection of tumor angiogenesis in vivo by alpha Vbeta3-targeted magnetic resonance imaging. Nat Med 1998; 4:623-626.
MedlineGoogle Scholar
35 Schaefer S, Van Tyen R, Saloner D. Evaluation of myocardial perfusion abnormalities with gadolinium-enhanced snapshot MR imaging in humans. Radiology 1992; 185:795-801.
Google Scholar
36 Knopp MV, Weiss E, Sinn HP, et al. Pathophysiologic basis of contrast enhancement in breast tumors. J Magn Reson Imaging 1999; 10:260-266.
MedlineGoogle Scholar
37 Wood DA, Miller M. The role of the dual pulmonary circulation in various pulmonary conditions of the lungs. J Thorac Surg 1938; 7:649-670.
Google Scholar
38 Wright D. The blood supply of abnormal tissues in the lungs. J Pathol 1938; 47:489-499.
Google Scholar
39 Cudkowicz L. Some observations of the bronchial arteries in lobar pneumonia and pulmonary infection. Br J Dis Chest 1952; 46:99-102.
Google Scholar
40 Cudkowicz L. The bronchial circulation in pulmonary tuberculosis In: the human bronchial circulation in health and disease. Baltimore, Md: Williams & Wilkins, 1968; 229-250.
Google Scholar
41 Charan NB, Turk GM, Dhand R. The role of bronchial circulation in lung abscess. Am Rev Respir Dis 1985; 131:121-124.
MedlineGoogle Scholar
42 Acute and chronic inflammation. In: Cotran RS, Kumar E V, Collins T, eds. Robbins pathologic basis of disease. 6th ed. Philadelphia, Pa: Saunders, 1999; 50-88.
Google Scholar
43 Levitzky MG. Blood flow to the lung In: Pulmonary physiology. 5th ed. New York, NY: McGraw-Hill, 1999; 85-111.
Google Scholar

Article History

Published in print: Aug 2002

Vol. 224, No. 2

Metrics

Altmetric Score

PDF download